Antibiotic definitive treatment in ventilator associated pneumonia caused by AmpC-producing Enterobacterales in critically ill patients: a prospective multicenter observational study
Matthieu Petit(Inserm), Guillaume Géri(Hôpital Avicenne), Paul Masi(Associated Research (United States)), Luc Haudebourg(Délégation Paris 7), Tomas Urbina(Sorbonne Université), Paris Meng(Sorbonne Université), Lara Zafrani(Inserm), Charles‐Édouard Luyt(Inserm), Jérémie Lemarie(Association de Recherche en Soins Infirmiers), Edwige Péju(Centre National de la Recherche Scientifique), Lucie Lefèvre, Benjamin Zuber(Hôpital Foch), Frank Bidar(Université Claude Bernard Lyon 1), Julien Dessajan(Sorbonne Université), Loïc Le Guennec(Sorbonne Université), Marine Paul(Centre Hospitalier de Versailles), Étienne de Montmollin(Inserm), Chloé Andriamifidy-Berti(Centre Hospitalier Intercommunal de Poissy), Marie Simon(Université Paris Cité), L Charrier(Centre Hospitalier Public du Cotentin), Florent Bavozet(Centre Hospitalier Universitaire de Tours), Quentin Fossé(Inserm)
Cited by 4
Related Papers
Ventilator-associated pneumonia in adults: a narrative review
|Intensive Care Medicine|2020|995
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
|The Lancet Respiratory Medicine|2020|477
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study
|Intensive Care Medicine|2021|421
Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock
|Intensive Care Medicine|2011|356